NCT06521060View on ClinicalTrials.gov

The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions

Not yet recruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2028

Conditions

Leiomyosarcoma

Interventions

PROCEDURE

tru cut biopsy

Proving that preoperative TCB could provide accurate information about the histological nature of the tumor would have great impact for setting an adequate, tailored, oncologically safe treatment approach.

Trial Locations (1)

12800

General hospital, Prague

All Listed Sponsors

lead

Charles University, Czech Republic

OTHER

NCT06521060 - The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions | Biotech Hunter | Biotech Hunter